C4 Therapeutics, Inc.

NasdaqGS:CCCC Stock Report

Mkt Cap: US$375.0m

C4 Therapeutics Financial Health

How is C4 Therapeutics's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: CCCC's short term assets ($325.5M) exceed its short term liabilities ($45.3M).

Long Term Liabilities: CCCC's short term assets ($325.5M) exceed its long term liabilities ($98.0M).


Debt to Equity History and Analysis

Debt Level: CCCC has more cash than its total debt.

Reducing Debt: Insufficient data to determine if CCCC's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CCCC has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: CCCC has sufficient cash runway for 2.2 years if free cash flow continues to reduce at historical rates of 51% each year.


Discover healthy companies